Clinical trial
Arimidex: Reason for and Effect of Change From Tamoxifen
NCT00246961 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Arimidex: Reason for and Effect of Change From Tamoxifen
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2004
- Completion date
- Not reported
- Enrollment
- 200
- Sites
- 33
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer